Best Practice & Research Clinical Rheumatology
Volume 23, Issue 6 , Pages 741-753 , December 2009

Quantifying the material and structural determinants of bone strength

  • Mary L. Bouxsein, PhD

      Affiliations

    • Assistant Professor of Orthopaedic Surgery, Orthopedic Biomechanics Laboratory, Beth Israel Deaconess Medical Center and Department of Orthopaedic Surgery, Harvard Medical School, RN115, 330 Brookline Ave, Boston, MA 02215, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 617 667 2940; Fax: +1 617 667 7175.
    • ,
  • Ego Seeman, MD

      Affiliations

    • Professor of Medicine, Austin Health, University of Melbourne, Melbourne, Australia

References 

  1. U.S. Department of Health and Human Services . Bone health and osteoporosis: a report of the surgeon general. Rockville, MD: U.S. Department of Health and Human Services, Office of the Surgeon General; 2004;
  2. Rosen CJ. Clinical practice. Postmenopausal osteoporosis. N Engl J Med. 2005;353(6):595–603
  3. Seeman E, Compston J, Adachi J, et al. Non-compliance: the Achilles' heel of anti-fracture efficacy. Osteoporos Int. 2007;18(6):711–719
  4. Proceedings of a symposium. Consensus Development Conference on Osteoporosis. October 19–20, 1990, Copenhagen, Denmark. Am J Med. 1991;91(5B):1S–68
  5. Bouxsein M. Biomechanics of age-related fractures. In:  Marcus R,  Feldman D,  Nelson D,  Rosen C editor. 3rd edn.. Osteoporosis. vol. I:San Diego, CA: Elsevier Academic Press; 2007;p. 601–616
  6. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005;20(7):1185–1194
  7. Siris ES, Chen YT, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med. 2004;164(10):1108–1112
  8. Wainwright SA, Marshall LM, Ensrud KE, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab. 2005;90(5):2787–2793
  9. Schuit SC, van der Klift M, Weel AE, et al. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone. 2004;34(1):195–202
  10. Cummings SR. How drugs decrease fracture risk: lessons from trials. J Musculoskelet Neuronal Interact. 2002;2(3):198–200
  11. Sarkar S, Mitlak BH, Wong M, et al. Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res. 2002;17(1):1–10
  12. Delmas P, Seeman E. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy. Bone. 2004;34(4):599–604
  13. Watts NB, Geusens P, Barton IP, Felsenberg D. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD. J Bone Miner Res. 2005;20(12):2097–2104
  14. Bouxsein ML. Bone quality: where do we go from here?. Osteoporos Int. 2003;14(Suppl. 5):118–127
  15. Seeman E, Delmas PD. Bone quality–the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354(21):2250–2261
  16. Engelke K, Gluer CC. Quality and performance measures in bone densitometry: part 1: errors and diagnosis. Osteoporos Int. 2006;17(9):1283–1292
  17. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ. 1996;312(7041):1254–1259
  18. WHO Study Group . Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: World Health Organization; 1994;
  19. Carter DR, Bouxsein ML, Marcus R. New approaches for interpreting projected bone densitometry. J Bone Miner Res. 1992;7:137–145
  20. Beck T. Measuring the structural strength of bones with dual-energy X-ray absorptiometry: principles, technical limitations, and future possibilities. Osteoporos Int. 2003;14(Suppl. 5):81–88
  21. Uusi-Rasi K, Beck TJ, Semanick LM, et al. Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporos Int. 2006;17(4):575–586
  22. Greenspan SL, Beck TJ, Resnick NM, et al. Effect of hormone replacement, alendronate, or combination therapy on hip structural geometry: a 3-year, double-blind, placebo-controlled clinical trial. J Bone Miner Res. 2005;20(9):1525–1532
  23. Uusi-Rasi K, Semanick LM, Zanchetta JR, et al. Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone. 2005;36(6):948–958
  24. Bonnick SL, Beck TJ, Cosman F, et al. DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass. Osteoporos Int. 2009;20(6):911–921
  25. Chen Z, Beck TJ, Cauley JA, et al. Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials. J Bone Miner Res. 2008;23(12):1935–1945
  26. Boivin GY, Chavassieux PM, Santora AC, et al. Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone. 2000;27(5):687–694
  27. Roschger P, Rinnerthaler S, Yates J, et al. Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone. 2001;29(2):185–191
  28. Boivin G, Lips P, Ott SM, et al. Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. J Clin Endocrinol Metab. 2003;88(9):4199–4205
  29. Borah B, Ritman EL, Dufresne TE, et al. The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover. Bone. 2005;37(1):1–9
  30. Misof BM, Roschger P, Cosman F, et al. Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment. J Clin Endocrinol Metab. 2003;88(3):1150–1156
  31. Beck TJ, Oreskovic TL, Stone KL, et al. Structural adaptation to changing skeletal load in the progression toward hip fragility: the study of osteoporotic fractures. J Bone Miner Res. 2001;16(6):1108–1119
  32. Beck TJ, Stone KL, Oreskovic TL, et al. Effects of current and discontinued estrogen replacement therapy on hip structural geometry: the study of osteoporotic fractures. J Bone Miner Res. 2001;16(11):2103–2110
  33. Crabtree N, Lunt M, Holt G, et al. Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone. 2000;27(1):151–159
  34. Nelson DA, Barondess DA, Hendrix SL, Beck TJ. Cross-sectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res. 2000;15(10):1992–1997
  35. Looker AC, Beck TJ, Orwoll ES. Does body size account for gender differences in femur bone density and geometry?. J Bone Miner Res. 2001;16(7):1291–1299
  36. Crabtree NJ, Kroger H, Martin A, et al. Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int. 2002;13(1):48–54
  37. Cauley JA, Lui LY, Stone KL, et al. Longitudinal study of changes in hip bone mineral density in Caucasian and African-American women. J Am Geriatr Soc. 2005;53(2):183–189
  38. Kaptoge S, Dalzell N, Loveridge N, et al. Effects of gender, anthropometric variables, and aging on the evolution of hip strength in men and women aged over 65. Bone. 2003;32(5):561–570
  39. Takada J, Beck TJ, Iba K, Yamashita T. Structural trends in the aging proximal femur in Japanese postmenopausal women. Bone. 2007;41(1):97–102
  40. Kaptoge S, Jakes RW, Dalzell N, et al. Effects of physical activity on evolution of proximal femur structure in a younger elderly population. Bone. 2007;40(2):506–515
  41. Kaptoge S, Dalzell N, Folkerd E, et al. Sex hormone status may modulate rate of expansion of proximal femur diameter in older women alongside other skeletal regulators. J Clin Endocrinol Metab. 2007;92(1):304–313
  42. Demissie S, Dupuis J, Cupples LA, et al. Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis Study. Bone. 2007;40(3):743–750
  43. Karasik D, Dupuis J, Cupples LA, et al. Bivariate linkage study of proximal hip geometry and body size indices: the Framingham study. Calcif Tissue Int. 2007;81(3):162–173
  44. Streeten EA, Beck TJ, O'Connell JR, et al. Autosome-wide linkage analysis of hip structural phenotypes in the Old Order Amish. Bone. 2008;43(3):607–612
  45. Szulc P, Duboeuf F, Schott AM, et al. Structural determinants of hip fracture in elderly women: re-analysis of the data from the EPIDOS study. Osteoporos Int. 2006;17(2):231–236
  46. Ahlborg HG, Nguyen ND, Nguyen TV, et al. Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res. 2005;20(10):1820–1827
  47. Rivadeneira F, Zillikens MC, De Laet CE, et al. Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study. J Bone Miner Res. 2007;22(11):1781–1790
  48. Kaptoge S, Beck TJ, Reeve J, et al. Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res. 2008;23(12):1892–1904
  49. Riggs BL, Melton Iii LJ, Robb RA, et al. Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites. J Bone Miner Res. 2004;19(12):1945–1954
  50. Marshall LM, Lang TF, Lambert LC, et al. Dimensions and volumetric BMD of the proximal femur and their relation to age among older U.S. men. J Bone Miner Res. 2006;21(8):1197–1206
  51. Sigurdsson G, Aspelund T, Chang M, et al. Increasing sex difference in bone strength in old age: the Age, Gene/Environment Susceptibility-Reykjavik study (AGES-REYKJAVIK). Bone. 2006;39(3):644–651
  52. Marshall LM, Zmuda JM, Chan BK, et al. Race and ethnic variation in proximal femur structure and BMD among older men. J Bone Miner Res. 2008;23(1):121–130
  53. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003;349(13):1207–1215
  54. Finkelstein JS, Hayes A, Hunzelman JL, et al. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med. 2003;349(13):1216–1226
  55. McClung MR, San Martin J, Miller PD, et al. Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med. 2005;165(15):1762–1768
  56. Sellmeyer DE, Black DM, Palermo L, et al. Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis. Osteoporos Int. 2007;18(7):973–979
  57. Lewiecki EM, Keaveny TM, Kopperdahl DL, et al. Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. J Clin Endocrinol Metab. 2009;94(1):171–180
  58. Miller PD, Delmas PD, Lindsay R, et al. Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. J Clin Endocrinol Metab. 2008;93(10):3785–3793
  59. Duboeuf F, Jergas M, Schott AM, et al. A comparison of bone densitometry measurements of the central skeleton in post-menopausal women with and without vertebral fracture. Br J Radiol. 1995;68(811):747–753
  60. Ito M, Ohki M, Hayashi K, et al. Trabecular texture analysis of CT images in the relationship with spinal fractures. Radiology. 1995;194:55–59
  61. Grampp S, Genant H, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res. 1997;12:697–711
  62. Lang TF, Li J, Harris ST, Genant HK. Assessment of vertebral bone mineral density using volumetric quantitative CT. J Comput Assist Tomogr. 1999;23(1):130–137
  63. Bergot C, Laval-Jeantet AM, Hutchinson K, et al. A comparison of spinal quantitative computed tomography with dual energy X-ray absorptiometry in European women with vertebral and nonvertebral fractures. Calcif Tissue Int. 2001;68(2):74–82
  64. Kroger H, Lunt M, Reeve J, et al. Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European quantitation of osteoporosis study. Calcif Tissue Int. 1999;64(3):191–199
  65. Lang TF, Guglielmi G, van Kuijk C, et al. Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. Bone. 2002;30(1):247–250
  66. Rehman Q, Lang T, Modin G, Lane NE. Quantitative computed tomography of the lumbar spine, not dual x-ray absorptiometry, is an independent predictor of prevalent vertebral fractures in postmenopausal women with osteopenia receiving long-term glucocorticoid and hormone-replacement therapy. Arthritis Rheum. 2002;46(5):1292–1297
  67. Clowes JA, Eastell R, Peel NF. The discriminative ability of peripheral and axial bone measurements to identify proximal femoral, vertebral, distal forearm and proximal humeral fractures: a case control study. Osteoporos Int. 2005;16(12):1794–1802
  68. Mackey DC, Eby JG, Harris F, et al. Prediction of clinical non-spine fractures in older black and white men and women with volumetric BMD of the spine and areal BMD of the hip: the Health, Aging, and Body Composition Study*. J Bone Miner Res. 2007;22(12):1862–1868
  69. Black DM, Bouxsein ML, Marshall LM, et al. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res. 2008;23(8):1326–1333
  70. Ito M, Ikeda K, Nishiguchi M, et al. Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk. J Bone Miner Res. 2005;20(10):1828–1836
  71. Graeff C, Timm W, Nickelsen TN, et al. Monitoring teriparatide-associated changes in vertebral microstructure by high-resolution CT in vivo: results from the EUROFORS study. J Bone Miner Res. 2007;22(9):1426–1433
  72. Boutroy S, Bouxsein ML, Munoz F, Delmas PD. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography. J Clin Endocrinol Metab. 2005;90(12):6508–6515
  73. Khosla S, Riggs BL, Atkinson EJ, et al. Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res. 2006;21(1):124–131
  74. Khosla S, Melton LJ, Achenbach SJ, et al. Hormonal and biochemical determinants of trabecular microstructure at the ultradistal radius in women and men. J Clin Endocrinol Metab. 2005;91(3):885–891
  75. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD. Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study. J Bone Miner Res. 2007;22(3):425–433
  76. Melton LJ, Riggs BL, van Lenthe GH, et al. Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res. 2007;22(9):1442–1448
  77. Vico L, Zouch M, Amirouche A, et al. High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res. 2008;23(11):1741–1750
  78. Riggs BL, Melton LJ, Robb RA, et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008;23(2):205–214
  79. Kazakia GJ, Hyun B, Burghardt AJ, et al. In vivo determination of bone structure in postmenopausal women: a comparison of HR-pQCT and high-field MR imaging. J Bone Miner Res. 2008;23(4):463–474
  80. Dalzell N, Kaptoge S, Morris N, et al. Bone micro-architecture and determinants of strength in the radius and tibia: age-related changes in a population-based study of normal adults measured with high-resolution pQCT. Osteoporos Int. 2009;20(10):1683–1694
  81. MacNeil JA, Boyd SK. Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys. 2007;29(10):1096–1105
  82. Boutroy S, Van Rietbergen B, Sornay-Rendu E, et al. Finite element analysis based on in vivo HR-pQCT images of the distal radius is associated with wrist fracture in postmenopausal women. J Bone Miner Res. 2008;23(3):392–399
  83. Seeman E, Delmas PD, Hanley DA, et al. Effects of denosumab and alendronate on skeletal microarchitecture International Bone and Mineral Society Meeting, Sydney. 2009.
  84. Rizzoli R, Felsenberg D, Laroche M, et al. Strontium ranelate has a more positive influence than alendronate on distal tibia cortical and trabecluar bone microstructure in women with postmenopausal osteoporosis. Osteoporos Int. 2009;20:165–166
  85. Boivin G, Meunier PJ. Changes in bone remodeling rate influence the degree of mineralization of bone. Connect Tissue Res. 2002;43(2–3):535–537
  86. Boivin G, Deloffre P, Perrat B, et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res. 1996;11(9):1302–1311
  87. Wehrli FW, Song HK, Saha PK, Wright AC. Quantitative MRI for the assessment of bone structure and function. NMR Biomed. 2006;19(7):731–764
  88. Wehrli FW. Structural and functional assessment of trabecular and cortical bone by micro magnetic resonance imaging. J Magn Reson Imaging. 2007;25(2):390–409
  89. Link TM, Majumdar S, Grampp S, et al. Imaging of trabecular bone structure in osteoporosis. Eur Radiol. 1999;9(9):1781–1788
  90. Wehrli FW, Saha PK, Gomberg BR, et al. Role of magnetic resonance for assessing structure and function of trabecular bone. Top Magn Reson Imaging. 2002;13(5):335–355
  91. Majumdar S, Newitt D, Mathur A, et al. Magnetic resonance imaging of trabecular bone structure in the distal radius: relationship with X-ray tomographic microscopy and biomechanics. Osteoporos Int. 1996;6(5):376–385
  92. Link TM, Vieth V, Stehling C, et al. High-resolution MRI vs multislice spiral CT: which technique depicts the trabecular bone structure best?. Eur Radiol. 2003;13(4):663–671
  93. Krug R, Banerjee S, Han ET, et al. Feasibility of in vivo structural analysis of high-resolution magnetic resonance images of the proximal femur. Osteoporos Int. 2005;16(11):1307–1314
  94. Banerjee S, Han ET, Krug R, et al. Application of refocused steady-state free-precession methods at 1.5 and 3T to in vivo high-resolution MRI of trabecular bone: simulations and experiments. J Magn Reson Imaging. 2005;21(6):818–825
  95. Blumenfeld J, Studholme C, Carballido-Gamio J, et al. Three-dimensional image registration of MR proximal femur images for the analysis of trabecular bone parameters. Med Phys. 2008;35(10):4630–4639
  96. Benito M, Gomberg B, Wehrli FW, et al. Deterioration of trabecular architecture in hypogonadal men. J Clin Endocrinol Metab. 2003;88(4):1497–1502
  97. Wehrli FW, Leonard MB, Saha PK, Gomberg BR. Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone. J Magn Reson Imaging. 2004;20(1):83–89
  98. Majumdar S, Genant HK, Grampp S, et al. Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging. J Bone Miner Res. 1997;12(1):111–118
  99. Wehrli FW, Hwang SN, Ma J, et al. Cancellous bone volume and structure in the forearm: noninvasive assessment with MR microimaging and image processing. Radiology. 1998;206(2):347–357
  100. Link TM, Majumdar S, Augat P, et al. In vivo high resolution MRI of the calcaneus: differences in trabecular structure in osteoporosis patients. J Bone Miner Res. 1998;13(7):1175–1182
  101. Majumdar S, Link TM, Augat P, et al. Trabecular bone architecture in the distal radius using magnetic resonance imaging in subjects with fractures of the proximal femur. Magnetic Resonance Science Center and Osteoporosis and Arthritis Research Group. Osteoporos Int. 1999;10(3):231–239
  102. Wehrli FW, Gomberg BR, Saha PK, et al. Digital topological analysis of in vivo magnetic resonance microimages of trabecular bone reveals structural implications of osteoporosis. J Bone Miner Res. 2001;16(8):1520–1531
  103. Link TM, Bauer JS. Imaging of trabecular bone structure. Semin Musculoskelet Radiol. 2002;6(3):253–261
  104. Benito M, Vasilic B, Wehrli FW, et al. Effect of testosterone replacement on trabecular architecture in hypogonadal men. J Bone Miner Res. 2005;20(10):1785–1791
  105. Chesnut CH, Majumdar S, Newitt DC, et al. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study. J Bone Miner Res. 2005;20(9):1548–1561
  106. Wu Y, Chesler DA, Glimcher MJ, et al. Multinuclear solid-state three-dimensional MRI of bone and synthetic calcium phosphates. Proc Natl Acad Sci U S A. 1999;96(4):1574–1578
  107. Wu Y, Ackerman JL, Chesler DA, et al. Density of organic matrix of native mineralized bone measured by water- and fat-suppressed proton projection MRI. Magn Reson Med. 2003;50(1):59–68
  108. Anumula S, Magland J, Wehrli SL, et al. Measurement of phosphorus content in normal and osteomalacic rabbit bone by solid-state 3D radial imaging. Magn Reson Med. 2006;56(5):946–952
  109. Wu Y, Dai G, Ackerman JL, et al. Water- and fat-suppressed proton projection MRI (WASPI) of rat femur bone. Magn Reson Med. 2007;57(3):554–567
  110. Cao H, Ackerman JL, Hrovat MI, et al. Quantitative bone matrix density measurement by water- and fat-suppressed proton projection MRI (WASPI) with polymer calibration phantoms. Magn Reson Med. 2008;60(6):1433–1443
  111. Robson MD, Gatehouse PD, Bydder GM, Neubauer S. Human imaging of phosphorus in cortical and trabecular bone in vivo. Magn Reson Med. 2004;51(5):888–892
  112. Stokstad E. Bone quality fills holes in fracture risk. Science. 2005;308(5728):1580
  113. Cody DD, Gross GJ, Hou FJ, et al. Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech. 1999;32(10):1013–1020
  114. Crawford RP, Cann CE, Keaveny TM. Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone. 2003;33(4):744–750
  115. Pistoia W, van Rietbergen B, Lochmuller EM, et al. Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images. Bone. 2002;30(6):842–848
  116. Pistoia W, van Rietbergen B, Laib A, Ruegsegger P. High-resolution three-dimensional-pQCT images can be an adequate basis for in-vivo microFE analysis of bone. J Biomech Eng. 2001;123(2):176–183
  117. Faulkner K, Cann C, Hasedawa B. Effect of bone distribution on vertebral strength: assessment with a patient-specific nonlinear finite element analysis. Radiology. 1991;179:669–674
  118. Melton LJ, Riggs BL, Keaveny TM, et al. Structural determinants of vertebral fracture risk. J Bone Miner Res. 2007;22(12):1885–1892
  119. Keaveny TM, Donley DW, Hoffmann PF, et al. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res. 2007;22(1):149–157
  120. Keaveny TM, Hoffmann PF, Singh M, et al. Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans. J Bone Miner Res. 2008;23(12):1974–1982
  121. Graeff C, Chevalier Y, Charlebois M, et al. Improvements in vertebral body strength under teriparatide treatment assessed in vivo by finite element analysis: results from the EUROFORS study. J Bone Min Res. 2009;24(10):1672–1680
  122. Lian KC, Lang TF, Keyak JH, et al. Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women. Osteoporos Int. 2005;16(6):642–650
  123. Newitt DC, Majumdar S, van Rietbergen B, et al. In vivo assessment of architecture and micro-finite element analysis derived indices of mechanical properties of trabecular bone in the radius. Osteoporos Int. 2002;13(1):6–17
  124. van Rietbergen B, Majumdar S, Newitt D, MacDonald B. High-resolution MRI and micro-FE for the evaluation of changes in bone mechanical properties during longitudinal clinical trials: application to calcaneal bone in postmenopausal women after one year of idoxifene treatment. Clin Biomech (Bristol, Avon). 2002;17(2):81–88

PII: S1521-6942(09)00101-6

doi: 10.1016/j.berh.2009.09.008

Best Practice & Research Clinical Rheumatology
Volume 23, Issue 6 , Pages 741-753 , December 2009

Article Tools

* Image Usage & Resolution